XENIOS
XENiOS AG developer of extracorporeal therapy systems., because the heart and the lungs are linked anatomically the right heart (ventricle) perfuses the lungs, while the left heart (ventricle) perfuses the body. No other company except XENIOS AG is offering minimally invasive disposable lung and heart therapies on one single platform.
XENIOS
Industry:
Health Care Medical Medical Device Therapeutics
Founded:
2013-01-01
Address:
Heilbronn, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.xenios-ag.com
Total Employee:
251+
Status:
Active
Contact:
+4971312706100
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Content Delivery Network Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Current Employees Featured
Josef Bogenschuetz CEO & President @ XENiOS
CEO & President
Georg Matheis Managing Director @ XENiOS
Managing Director
Dr. Benjamin Waldmann CEO @ XENiOS
CEO
2022-07-01
Jurgen Bohm Managing Directo, Chief Marketing and Medical Officer @ XENiOS
Managing Directo, Chief Marketing and Medical Officer
Knut Jöchle Vice President - Product Life Cycle & Quality Processes @ XENiOS
Vice President - Product Life Cycle & Quality Processes
Investors List
Zukunftsfonds Heilbronn
Zukunftsfonds Heilbronn investment in Seed Round - XENiOS
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-09-21 | XOR Labs Toronto | XENiOS investment in Venture Round - XOR Labs Toronto | 2.85 M CAD |
| 2016-02-22 | XOR Labs Toronto | XENiOS investment in Venture Round - XOR Labs Toronto | 2.6 M CAD |
Newest Events participated
Official Site Inspections
http://www.xenios-ag.com Semrush global rank: 7.7 M Semrush visits lastest month: 446
- Host name: xe-srv1-ip1.xenios-ag.com
- IP address: 81.169.218.109
- Location: Filderstadt Germany
- Latitude: 48.657
- Longitude: 9.2205
- Timezone: Europe/Berlin
- Postal: 70794
More informations about "XENiOS"
Xenios AG is specialized in extracorporeal heart and lung support
End of 2016, Xenios AG became a part of Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure. 2013. Novalung and Medos …See details»
XENIOS AG - HealthManagement.org
Xenios AG Announces Changes in the Management Board . 2021 31 Mar The Management Board of Xenios AG , the Heart & Lung Business Unit of Fresenius Medical Care, has been …See details»
XENiOS - Crunchbase Company Profile & Funding
Sep 24, 2015 XENiOS AG developer of extracorporeal therapy systems., because the heart and the lungs are linked anatomically the right heart (ventricle) perfuses the lungs, while the left …See details»
Xenios AG - a Fresenius Medical Care company | LinkedIn
At Xenios, a Fresenius Medical Care company, we offer ECMO treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we ...See details»
ECMO with Xenios console
The World Health Organization (WHO) recommended ECMO treatment for the recovery of the most serious ill COVID-19 patients, ... For further information on country-specific regulations, …See details»
Xenios Console - HealthManagement.org
End of 2016, Xenios became a part of Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure. Xenios AG 74076 Heilbronn · …See details»
Xenios AG Announces Changes in the Management Board
Mar 31, 2021 The Management Board of Xenios AG, the Heart & Lung Business Unit of Fresenius Medical Care, has been restructured.Effective January 31, 2021, the previous Chair …See details»
Fresenius Medical Care acquires XENIOS AG - pressebox.com
Nov 9, 2016 XENIOS AG, the technology and therapy leader in lung and heart assist becomes part of Fresenius Medical Care & Co. KGaA, Germany’s largest medical device company. - …See details»
Xenios - Overview, News & Similar companies | ZoomInfo.com
Jul 13, 2021 Xenios AG - a company of the Fresenius Medical Care Group - is a pioneer in extracorporeal heart and lung support. The Novalung and Medos products offer a wide range …See details»
Changes in the Management Board of Xenios AG
Mar 31, 2021 The Management Board of Xenios AG, the Heart & Lung Business Unit of Fresenius Medical Care, has been restructured. Effective January 31, 2021, the previous …See details»
Fresenius Medical Care is taking the next step in extracorporeal life ...
Oct 15, 2024 Xenios 2.0 was developed according to the principles of safety, simplicity, and connectivity; Heilbronn (October 15, 2024) Fresenius Medical Care’s heart & lung business …See details»
Merger: Medos Becomes Fully Integrated Within Xenios AG
Sep 1, 2022 Medos Medizintechnik AG (Medos) was founded in 1987 with a focus on cardiopulmonary solutions. Together with Novalung GmbH (Novalung), the company was …See details»
XENIOS AG - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for XENIOS AG of Heilbronn, Baden-Württemberg. Get the latest business insights from Dun & Bradstreet.See details»
ECLS with XENIOS 2.0 - Xenios AG
Xenios 2.0 can simplify this process with its integrated interface for seamless data transfer. The system can support with efficiency and reliability in medical data management through …See details»
Xenios Company Profile - Office Locations, Competitors ... - Craft
Xenios is a company specializing in minimally invasive lung and heart assist. It offers extracorporeal solutions for the treatment of acute and chronic lung failure with a product …See details»
Fresenius Medical Care acquires XENIOS AG
Nov 9, 2016 The integration of the expertise from XENIOS and Fresenius Medical Care is a sound basis to establish worldwide market leadership from renal to lung and heart assist. …See details»
Xenios AG receives approval in China for ECMO devices
Jul 13, 2021 Xenios AG, a Fresenius Medical Care company, has received approval from the National Medical Products Administration (NMPA) in China for the Xenios console and patient …See details»
Fresenius Medical Care acquires XENIOS AG
Nov 8, 2016 XENIOS AG’s Novalung product range for lung assist is a perfect match with renal dialysis. „This acquisition is a unique opportunity for Fresenius Medical Care to add to their …See details»
Merger: Medos Becomes Fully Integrated Within Xenios AG
Sep 1, 2022 Medos Medizintechnik AG (Medos) was founded in 1987 with a focus on cardiopulmonary solutions. Together with Novalung GmbH (Novalung), the company was …See details»